Delivery Order SPE2DB22D3004-SPE2DB26FQ80C
- Not listed
- The Defense Logistics Agency awarded a $26,579.88 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price contract represents a small component of the vendor's extensive pharmaceutical supply operations supporting federal medical procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $31.3K firm fixed price delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5ml) with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract reflects AmerisourceBergen's ongoing role as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order was performed at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,843.69 for Rotarix vaccine oral syringes (1.5 mL) with a completion date of July 30, 2025. This competitive award, issued on July 29, 2025, carries firm fixed-price terms and involves no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,443.00 to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) with a firm fixed price structure. The contract is unclassified with no set-aside designation and was competitively awarded on August 22, 2025, with an ultimate completion date of August 25, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,067.22 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine oral syringes (1.5mL) with a firm fixed price structure. The contract, which was competitively awarded with no set-aside designation, is scheduled for ultimate completion on April 25, 2025, one day after the award date of April 24, 2025. Performance will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $11,074.95 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine oral syringes (1.5mL). The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of May 30, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe format (1.5 mL) under a firm fixed price contract valued at $11,884.18. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at...
- The Defense Logistics Agency awarded a delivery order valued at $24,953.40 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe 1.5ml format. This firm fixed-price contract, with an ultimate completion date of September 2, 2025, was competitively awarded without set-aside designation. The performance location is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single procurement action under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $6,644.97 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe format (1.5 milliliter units). This firm fixed-price delivery order, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,696.28 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Rotarix vaccine oral syringes in 1.5ml quantities. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 3, 2025, and was competitively awarded with no set-aside designation. This award represents a child contract issued under...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB26FQ80CDelivery Order
The Defense Logistics Agency (DLA) awarded a $11,148.36 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) on October 29, 2025, with completion scheduled for October 30, 2025. This firm fixed-price contract, which was competitively awarded without set-aside designation, will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical support vehicle valued through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with the DLA Medical Supply Chain, covering a wide spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This contract reflects AmerisourceBergen's demonstrated capability to meet federal procurement requirements through competitive procurement and supports the Defense Health Agency and other government healthcare systems through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 10/29/25 |